Safety and Efficacy of Therapeutic INduced HYPERTENSION in Acute Non-cardioembolic Ischemic Stroke (SETIN-HYPERTENSION)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 170 participants.

Also called NCT01600235

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 170 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01600235
Other papers using this trial's data
  • Therapeutic-induced hypertension in patients with noncardioembolic acute stroke Neurology, 2019-11-19 DOI, PubMed 31645472, PMC6885575 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01600235. Randomized; no masking; primary purpose treatment. Start 2012-06 (registry gives no type); primary completion 2017-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy of Therapeutic INduced HYPERTENSION in Acute Non-cardioembolic Ischemic Stroke (SETIN-HYPERTENSION)
Condition
Stroke, Acute
Condition
Progressing Stroke
Intervention (Drug)
Phenylephrine
Lead sponsor
Samsung Medical Center (class: other)
Collaborator
Inje University (class: other)
Collaborator
Gyeongsang National University Hospital (class: other)
Collaborator
Seoul National University Bundang Hospital (class: other)
Collaborator
Keimyung University Dongsan Medical Center (class: other)
Collaborator
Yeungnam University Hospital (class: other)

Record details

Record id
cardio:ct-nct01600235
Content hash
bef6226d740f78574d21a6cc1b919bd1ed3fe94a858768b81da1713660890ae8